News
The Phase-3 Trials of Covaxin Ensure Unparalleled Safety Against the Covid-19 Virus With: ... - Latest Tweet by Prasar Bharati News Services
The latest Tweet by Prasar Bharati News Services states, 'The phase-3 trials of Covaxin ensure unparalleled safety against the Covid-19 virus with: - 93% efficacy against severe Covid-19 disease, reducing hospitalizations - 78% efficacy against mild, moderate, and severe Covid-19 disease'
The phase-3 trials of Covaxin ensure unparalleled safety against the Covid-19 virus with:
- 93% efficacy against severe Covid-19 disease, reducing hospitalizations
- 78% efficacy against mild, moderate, and severe Covid-19 disease pic.twitter.com/GcAtP1SG29— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) July 3, 2021
(The above story first appeared on LatestLY on Jul 03, 2021 10:24 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
